
ASTRAZEN.NS Technical Analysis Summary (NSE)
Analyze ASTRAZEN.NS on the NSE with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerASTRAZEN.NS Technical Analysis Summary (NSE)
AstraZeneca Pharma India Limited (NSE: ASTRAZEN.NS) stock currently shows a bearish trend on the NSE, supported by momentum and weak buying pressure.
Technical conditions suggest AstraZeneca Pharma India Limited on the NSE is awaiting a decisive move. Overall, AstraZeneca Pharma India Limited remains neutral, with indicators showing mixed momentum.
RSI (14): 27.18
Stochastic %K: 3.07
Williams %R: -95.23
Rate of Change (ROC): -10.66
Takeaway:AstraZeneca Pharma India Limited shows oversold momentum, with rebound potential building.
MACD: -179.92
ADX: 25.28
ATR (14): 197.44
CCI (14): -126.71
Takeaway:AstraZeneca Pharma India Limited shows oversold trend conditions, with potential for rebound if buyers step in.
Takeaway:AstraZeneca Pharma India Limited trades closer to support, showing weaker momentum within bands.
Takeaway:AstraZeneca Pharma India Limited trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:ASTRAZEN.NS shows oversold money flow, with rebound potential building.
Bullish Signals
ADX above 20 → strong underlying trend.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:AstraZeneca Pharma India Limited shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.